Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Clinical trial NCT02007512 · COMPLETED
Trial details
- NCT number
- NCT02007512
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-16
- Primary completion
- 2016-09-23
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.